Innovation Update

Weekend Reading: On the Edge

Stock quotes in this article: ^DJI , ^IXIC , ^GSPC , WM , WAG , CC , SCS  

Good Sunday afternoon, and welcome to Weekend Reading. First, a look back at the week that just finished, then a look forward to the week ahead, and finally, a summary of articles and papers worth reading.

We teetered on a precipice again last week. Credit markets locked up, risk spreads were at historical levels and we had the largest bank failure in U.S. history. All the while, Congress fiddled and played politics. The result: declines in all three major U.S. indices, and a clear sense that another week without a bailout would be a disaster.

Looking forward to next week, it seems highly likely we will have a bailout deal in place. It isn't perfect, but it's better than the alternative of doing nothing, or of spending more time messing about trying to come with something perfect. It also seems likely that the legislation's political passage will not be smooth, with members on both sides of the Congress in the U.S. House and Senate unhappy, irritated, and generally nervous about the proximity of this bailout to the November elections.

At the same time, economic data next week will almost certainly make it clear that the U.S. economy is in recession. It has wobbled on the brink for some time, but there is no way out now that I can see. We will join other major economies that are either already in recessions or on their way there.

Next week is chock-full of economic indicators. On Friday we'll have the nonfarm payrolls report, which will almost certainly be grim (likely 100,000-plus job losses). Also next week, we'll see the S&P/Case-Shiller Home Price Index, plus a September measure of manufacturing activity, and consumer confidence.

Turning to earnings, next week will see reports from Circuit City(CC Quote), Walgreen(WAG Quote) and Steelcase(SCS Quote) among others.

Finally, here are some articles and papers worth reading:

Editor's note: To access some of these stories, registration or a subscription may be required. Please check the individual links for the site's policy.

  • Loading Comments...
  •  

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
At time of publication, Kedrosky had no positions in stocks mentioned, although holdings can change at any time.

Dr. Paul Kedrosky is a former highly ranked sell-side technology equity analyst, and he currently runs a technology finance institute at the University of California, San Diego. He is also a venture partner with Ventures West, an institutional venture capital firm with more than $400 million under management. He maintains a widely read blog called Infectious Greed.

Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. While Kedrosky cannot provide investment advice or recommendations, he appreciates your feedback; click here to send him an email.





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,197.47 1,087.24 2,149.02 34.46
Oil *
75.80
DOWN
93.79
DOWN
11.27
DOWN
17.88
DOWN
0.28
10 Yr
3.45%
SPDR Gold
108.21
-0.91%
-1.03%
-0.83%
-0.81%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services